Developer docs
API playgroundTry for free, no card

Search company profiles

Penington Institute

Full company profile

uuid0039byv

Namestring
Penington Institute
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Penington Institute operates a website at the Australian top-level domain penington.org.au, indicating an Australian-based organization; the ".org.au" domain and the use of "Institute" in the organization name are consistent with a non-profit, research, policy, or community-sector entity rather than a commercial enterprise.

No substantive company information was available in the supplied input data. All structured fields — including revenue, headcount, products and services, customer segments, value proposition, pricing, technology stack, partnerships, awards, leadership team, funding history, office locations, operating geographies, and corporate timeline — were returned as empty or explicitly marked as unavailable. The sole source ID is described in the input as a placeholder/loading page with no substantive company data, and the raw content associated with the company URL consists solely of "One moment, please" and "Loader" text fragments.

As a result, the company's specific line of business, products, business model, customer base, and revenue mechanics cannot be described from the supplied material. Any downstream investment, competitive, or operating analysis should be deferred until substantive first-party or third-party data is available. This description intentionally avoids inferring functional details that are not supported by the input.

Short descriptiontext

Penington Institute is an Australian organization operating at penington.org.au; the supplied input data contains no substantive information about its products, customers, business model, or operations beyond its name and website URL.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

No data
Social media profiles1 record
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

No substantive information available. The provided source content was a placeholder/loading page with no descriptive content about the company's offerings.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
1European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
TypeBroad incumbent
Description

EU reference agency providing evidence-based data on drugs and drug policy. Comparable in evidence-generation and policy advisory function to Penington Institute, though at much larger scale and jurisdictional scope.

TypeDirect peer
Description

Leading US-based organization advocating for drug policies grounded in science, compassion, and human rights. Directly comparable in scope to Penington Institute's drug policy reform and harm reduction mandate.

TypeBroad incumbent
Description

US national nonprofit focused on addiction treatment access and substance use disorder policy. Comparable in advocacy and education mandate, broader in US treatment-system scope than Penington Institute.

TypeDirect peer
Description

Australia-wide organization supporting families affected by alcohol and other drug use. Comparable in community-facing harm reduction services and Australian geography to Penington Institute.

TypeDirect peer
Description

International NGO promoting harm reduction approaches to drug use and evidence-based drug policy reform. Comparable in mission and advocacy positioning to Penington Institute's harm reduction and overdose-focused work.

TypeDirect peer
Description

Victorian peak body for harm reduction and drug user organisations. Operates in the same Australian harm reduction ecosystem with directly overlapping service and advocacy scope.

TypeDirect peer
Description

Australia's leading organization preventing alcohol and other drug harm through education, advocacy, and community programs. Closest direct Australian peer in mission and target audience to Penington Institute.

TypeDirect peer
Description

Canadian national body providing evidence-based analysis on substance use. Comparable in research, policy advisory, and harm reduction orientation to Penington Institute.

TypeDirect peer
Description

National peak body representing Australia's alcohol and other drug sector. Comparable in policy advocacy, sector representation, and harm reduction orientation to Penington Institute.

TypeDirect peer
Description

Australian national peak body representing people who use drugs, with directly overlapping peer-led harm reduction and drug policy advocacy activities relative to Penington Institute.

Market position
Customer concentration

Classification, Details

No data
Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Penington Institute

Penington Institute is an Australian organization operating at penington.org.au; the supplied input data contains no substantive information about its products, customers, business model, or operations beyond its name and website URL.

What Penington Institute does

Penington Institute operates a website at the Australian top-level domain penington.org.au, indicating an Australian-based organization; the ".org.au" domain and the use of "Institute" in the organization name are consistent with a non-profit, research, policy, or community-sector entity rather than a commercial enterprise.

No substantive company information was available in the supplied input data. All structured fields — including revenue, headcount, products and services, customer segments, value proposition, pricing, technology stack, partnerships, awards, leadership team, funding history, office locations, operating geographies, and corporate timeline — were returned as empty or explicitly marked as unavailable. The sole source ID is described in the input as a placeholder/loading page with no substantive company data, and the raw content associated with the company URL consists solely of "One moment, please" and "Loader" text fragments.

As a result, the company's specific line of business, products, business model, customer base, and revenue mechanics cannot be described from the supplied material. Any downstream investment, competitive, or operating analysis should be deferred until substantive first-party or third-party data is available. This description intentionally avoids inferring functional details that are not supported by the input.

Penington Institute firmographics

Firmographics
Name
Penington Institute
Website
https://penington.org.au
Company type
Private
Founded year
2014
Headcount range
11–50 employees
Short description
Penington Institute is an Australian organization operating at penington.org.au; the supplied input data contains no substantive information about its products, customers, business model, or operations beyond its name and website URL.
Ownership category
akta.pro rank

Where Penington Institute is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Markets served

Penington Institute business model

Business model
GTM type
B2B
Offering type
Services

Penington Institute product offering

Product offering

Core offering

No substantive information available. The provided source content was a placeholder/loading page with no descriptive content about the company's offerings.

Differentiator

Problem solved

Functional benefit

Penington Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Penington Institute competitors and assessment

Company assessment

Broad incumbents

  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): EU reference agency providing evidence-based data on drugs and drug policy. Comparable in evidence-generation and policy advisory function to Penington Institute, though at much larger scale and jurisdictional scope.
  • Shatterproof: US national nonprofit focused on addiction treatment access and substance use disorder policy. Comparable in advocacy and education mandate, broader in US treatment-system scope than Penington Institute.

Direct peers

  • Drug Policy Alliance: Leading US-based organization advocating for drug policies grounded in science, compassion, and human rights. Directly comparable in scope to Penington Institute's drug policy reform and harm reduction mandate.
  • Family Drug Support Australia: Australia-wide organization supporting families affected by alcohol and other drug use. Comparable in community-facing harm reduction services and Australian geography to Penington Institute.
  • Harm Reduction International: International NGO promoting harm reduction approaches to drug use and evidence-based drug policy reform. Comparable in mission and advocacy positioning to Penington Institute's harm reduction and overdose-focused work.
  • Harm Reduction Victoria: Victorian peak body for harm reduction and drug user organisations. Operates in the same Australian harm reduction ecosystem with directly overlapping service and advocacy scope.
  • Alcohol and Drug Foundation: Australia's leading organization preventing alcohol and other drug harm through education, advocacy, and community programs. Closest direct Australian peer in mission and target audience to Penington Institute.
  • Canadian Centre on Substance Use and Addiction (CCSA): Canadian national body providing evidence-based analysis on substance use. Comparable in research, policy advisory, and harm reduction orientation to Penington Institute.
  • Australian Alcohol and other Drugs Council (AADC): National peak body representing Australia's alcohol and other drug sector. Comparable in policy advocacy, sector representation, and harm reduction orientation to Penington Institute.
  • Australian Injecting and Illicit Drug Users League (AIVL): Australian national peak body representing people who use drugs, with directly overlapping peer-led harm reduction and drug policy advocacy activities relative to Penington Institute.

Market position

Customer concentration

Penington Institute social profiles

Digital presence

Penington Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Penington Institute leadership team

Management profile

Number of profiles

Penington Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Penington Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Penington Institute

What does Penington Institute do?

No substantive information available. The provided source content was a placeholder/loading page with no descriptive content about the company's offerings.

When was Penington Institute founded?

Penington Institute was founded in 2014. It employs 11 to 50 people.

Where is Penington Institute based?

Penington Institute is headquartered in Melbourne, Australia, in the Oceania region.

Who are Penington Institute's main competitors?

Broad incumbents on record are European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Shatterproof. Direct peers are Drug Policy Alliance, Family Drug Support Australia, Harm Reduction International, Harm Reduction Victoria, Alcohol and Drug Foundation, Canadian Centre on Substance Use and Addiction (CCSA), Australian Alcohol and other Drugs Council (AADC) and Australian Injecting and Illicit Drug Users League (AIVL).

Does Penington Institute have an API?

No public API is recorded for Penington Institute.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ABCQueensland records its highest ever annual number of drug overdose deathsQueensland recorded 417 unintentional overdose deaths in 2024, its highest annual total, with national deaths surpassing 2,000. The Penington Institute report calls the deaths preventable, while the Queensland government cited $394.4 million in mental health and drug services funding.Mirage NewsOver-50s Most at Risk for Drug OverdoseThe Penington Institute's latest report reveals that Australians aged 50-59 now represent the highest proportion of unintentional drug overdose deaths in Australia (25.5%), surpassing younger age groups for the first time in a decade. Prescription medications, particularly pharmaceutical opioids and benzodiazepines, contribute to nearly half of all unintentional overdoses, with over 70% of deaths involving two or more drug types. The trend is attributed to an aging cohort of long-term drug users, polypharmacy among older adults managing chronic conditions, and barriers to screening and treatment for this demographic.ABCSeven Australians are dying each day from drug overdose in worst year on record, researchers sayAustralia recorded its deadliest overdose year on record in 2024, with 2,596 people dying from drug overdose — approximately one person every 3.5 hours — according to new analysis by the Penington Institute, with 80 percent of deaths being unintentional drug-induced fatalities. Stimulant-related deaths increased by 25.1 percent in 12 months, driven primarily by methamphetamine, while the 50-59 age group recorded the highest number of unintentional overdose deaths for the first time. Drug researchers are calling for greater investment in harm reduction, noting that only 2 percent of government funding goes to harm reduction versus 64 percent to law enforcement, and that only half of people seeking treatment are able to receive it.